100
Participants
Start Date
December 1, 2022
Primary Completion Date
October 31, 2024
Study Completion Date
December 31, 2026
Prostate hyperplasia medication
The dosages prostatic hyperplasia medication: dutasteride 0,5 MG x1 or finasteride 5 MG x1 or combination of dutasteride and tamsulosin 0,5/0,4 MG x1.
LhRH-antagonist
The starting dose in prostatic cancer patient cohort of LHRH antagonist degarelix is 120 MGx2 and the maintenance dose is 80 MGx1.
RECRUITING
Turku University Hospital, Turku
RECRUITING
University of Turku, Turku
Turku University Hospital
OTHER_GOV